"HIV Testing Bans Won't End `Testing'"

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

"HIV Testing Bans Won't End `Testing'"

Wall Street Journal (12/27/91), P. A10
Clark, Lindley H.

Abstract: HIV testing will most likely continue even though the Americans With Disabilities Act will be implemented next July, writes Lindley H. Clark Jr. of the Wall Street Journal. The act bans employers with 25 or more people from discriminating against an individual with a disability or a perceived one. The Americans with Disabilities Act would seem to end controversy over HIV testing, but it probably won't. David E. Bloom and Sherry Glied, economists from Columbia University, published a report in Science magazine that asseses the costs and benefits for HIV testing. They determined that small firms and large firms which weigh the costs and benefits would be unlikely to test employees. Instead, employers may deny workers a job if they appear to be in a high risk group. Employers might also limit the eligibility and benefits of their health-care programs. Businesses must not lose sight of profit and generating income, Clark concludes. Though it may sound callous, the only way the epidemic can be cured is if economic factors are faced.

911227
AD912303

Copyright © 1991 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.